
Commentary|Podcasts|February 10, 2026
Pharmacist-Led Strategies Offer Solutions to Ongoing Hypertension Control Failures
Fact checked by: Ron Panarotti
Host Craig Beavers explores why US blood pressure control still lags despite proven treatments.
Advertisement
In this American Heart Month solo episode of the Tell-Tale Heart podcast, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, examines the “hypertension control paradox” outlined in a recent New England Journal of Medicine perspective, exploring why blood pressure control in the United States remains suboptimal despite effective therapies and long-standing clinical guidelines. Beavers reviews national trends showing stalled progress in hypertension control and contrasts them with higher-performing systems that rely on protocol-driven, team-based care models.
Join us for an insightful discussion.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Paradigm Shift in Lipid Management: Highlights from the NLA 2026 Scientific Sessions Opening Session
2
ATTR-CM Red Flags, Treatment Evidence, and the Pharmacist's Role in Care
3
Anticoagulation in AFib: Risk Stratification, Therapy Selection, and Factor XI Inhibitors
4
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant Treatment of High-Risk Clear Cell RCC
5


































































































































